Health services

Tender description

North of England Commissioning Support (NECS) is a commissioning support service hosted by NHS England and is managing this procurement process for and on behalf of Greater Manchester Health and Social Care Partnership. This tender opportunity is for the provision of Diabetic Eye Screening Programme in Greater Manchester covering 2 Lots: Lot 1: Greater Manchester North, Lot 2: Greater Manchester South. Tenderers can bid on both Lots. Tender documents will be available on PROACTIS from 14.6.2018. The aim of the service is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, and population-based screening programmes that: — identify the eligible population and ensure effective delivery with maximum coverage, — are safe, effective, of a high quality, externally and independently monitored, and quality assured, — lead to earlier detection, appropriate referral, effective treatment and improved outcomes, — are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes; and, — have audit embedded in the service. The contract term will be for an initial period of 3 years with the option to extend the contract by a further 24 months at the discretion of the Contracting Authority and subject to satisfactory contractual and financial performance. The aim of the service is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, and population-based screening programmes that: — identify the eligible population and ensure effective delivery with maximum coverage, — are safe, effective, of a high quality, externally and independently monitored, and quality assured, — lead to earlier detection, appropriate referral, effective treatment and improved outcomes, — are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes, and — have audit embedded in the service. The contract term will be for an initial period of 3 years with the option to extend the contract by a further 24 months at the discretion of the Contracting Authority and subject to satisfactory contractual and financial performance.